Package 51655-734-52

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51655-734-52
Digits Only 5165573452
Product NDC 51655-734
Description

30 TABLET in 1 BOTTLE, PLASTIC (51655-734-52)

Marketing

Marketing Status
Marketed Since 2021-06-17
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4963a8f3-e774-0c08-e063-6394a90a6a17", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897640"], "spl_set_id": ["db990ce1-b193-4a81-e053-2a95a90a627b"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (51655-734-52)", "package_ndc": "51655-734-52", "marketing_start_date": "20210617"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "51655-734_4963a8f3-e774-0c08-e063-6394a90a6a17", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51655-734", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20210617", "listing_expiration_date": "20271231"}